Literature DB >> 16323390

Disability and health-related quality of life in Guillain-Barré syndrome during the first two years after onset: a prospective study.

Anette Forsberg1, Raymand Press, Ulrika Einarsson, Jésus de Pedro-Cuesta, Lotta Widén Holmqvist.   

Abstract

OBJECTIVE: To describe changes in disability and health-related quality of life in patients with Guillain-Barré syndrome in Sweden during the first two years after onset.
SUBJECTS: Forty-four patients were recruited from eight different hospitals, and 42 of them (mean age 52 years) were followed for two years. Evaluations were performed, primarily as home visits, at two weeks, two months, six months, one year and two years after onset. MAIN MEASURES: Disability was measured using the Katz Personal and Extended Activities of Daily Living Indexes, the Barthel Index, the Frenchay Activity Index and assessments of work capacity; health-related quality of life using the Sickness impact Profile.
RESULTS: At two weeks, one year and two years after onset of Guillain-Barré syndrome, 76%, 14% and 12% of patients were dependent in personal activities of daily life (ADL); and 98%, 28% and 26% were dependent in instrumental ADL. At two weeks, all of the patients that were working before onset were unable to work owing to Guillain-Barré syndrome; at two years, 17% were unable to work. At two weeks, scores on Sickness Impact Profile were elevated in all dimensions; at two years, they remained elevated in the physical dimension and in the categories home management, work and recreation and pastimes.
CONCLUSIONS: The impact of Guillain-Barré syndrome on ADL, work, social activities and health-related quality is considerable two years after onset and presumably persists beyond this time point.

Entities:  

Mesh:

Year:  2005        PMID: 16323390     DOI: 10.1191/0269215505cr918oa

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  7 in total

1.  Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

Authors:  F Khan; J F Pallant; L Ng; A Bhasker
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

2.  Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy.

Authors:  Claire M White; Robert D Hadden; Sarah F Robert-Lewis; Paul R McCrone; Jane L Petty
Journal:  BMC Neurol       Date:  2015-08-21       Impact factor: 2.474

3.  Functional outcomes and efficiency of rehabilitation in a national cohort of patients with Guillain-Barré syndrome and other inflammatory polyneuropathies.

Authors:  Roxana Alexandrescu; Richard John Siegert; Lynne Turner-Stokes
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

4.  The epidemiology of Guillain-Barré Syndrome in U.S. military personnel: a case-control study.

Authors:  Laura Nelson; Robert Gormley; Mark S Riddle; David R Tribble; Chad K Porter
Journal:  BMC Res Notes       Date:  2009-08-26

5.  Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.

Authors:  Bhasker Amatya; Fary Khan; Michael Whishaw; Julie F Pallant
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

6.  Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Fernando J García López; José Ramón Ara-Callizo; Fuencisla Avellanal; Carlos Casasnovas; Carlos Cemillán; José Ignacio Cuadrado; Jacinto Duarte; María Dolores Fernández-Pérez; Óscar Fernández; Juan Antonio García Merino; Rosa García Montero; Dolores Montero; Julio Pardo; Francisco Javier Rodríguez-Rivera; María Ruiz-Tovar; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

7.  Exploring the experiences of having Guillain-Barré Syndrome: A qualitative interview study.

Authors:  Joseph N A Akanuwe; Despina Laparidou; Ffion Curtis; Jennifer Jackson; Timothy L Hodgson; Aloysius Niroshan Siriwardena
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.